The role of glucagon secreton for glycemic control in patients with type 1 diabetes or pancreatic diabetes
Not Applicable
- Conditions
- Type 1 diabetes, Pancreatic diabetes
- Registration Number
- JPRN-UMIN000020156
- Lead Sponsor
- agasaki University Hospital
- Brief Summary
The levels of plasma glucagon were elevated and peaked 30 min after the mixed meal ingestion. The glucagon increments from fasting to each time point in type 1 diabetes patients were comparable to those in type 2 diabetes patients. Among the type 1 diabetes patients, the glucagon response showed no differences between the subgroups based on diabetes duration and fasting C-peptide levels.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
Not provided
Exclusion Criteria
Pregnant women Women who lactates
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The relationship of glucagon secretion and fluctuation of glucose revels.
- Secondary Outcome Measures
Name Time Method